º¸Ãæ¼ö Refill USP ±ÔÁ¤Áöħ ÀÔ´Ï´Ù.sink conditionÀÇ ±âº» Á¶°Ç ÀÔ´Ï´Ù.
1. ÷ºÎÀÚ·áÀÇ 1page
: Parenteral DrugÀÇ Performance Test Method Development´Â
½Ã·áÀÇ »óÅ¿¡ µû¶ó¼ ´Ù¸¥ ¹æ¹ýÀ» Á¦¾ÈÇϴµ¥
¿¹¸¦µé¾î
°£´ÜÇÑ ½Ã·á´Â USP 2 (Paddle)¹æ¹ýÀ»
º¹ÀâÇÑ ½Ã·á´Â USP 4( Flow-Through Cell)¹æ¹ýÀ» ¼±È£ÇÕ´Ï´Ù
Method Develoment ¿Í Validation¿¡ °üÇÏ¿© 1092ÀÇ Guide¸¦ ÂüÁ¶ÇÕ´Ï´Ù
* ÷ºÎ gc_1092 : Dissolution ProcedureÀÇ Development¿Í Validation¿¡
´ëÇÏ¿© ÃÖ±Ù¿¡ UpdateµÇ¾î Automation¿¡ ÀÇÇÑ °úÁ¤ ±â·ÏÃßÀûµî À» GuideÇÏ°í ÀÖ½À´Ï´Ù
HPLCÀÇ ºÐ¼®¹æ¹ý Development/Validation/Automation°ú À¯»çÇÕ´Ï´Ù
2. ÷ºÎÀÚ·áÀÇ 1-4 page
: Performance Test¿¡ »ç¿ëÇÒ ºÐ¼®¹æ¹ýÀåºñ¿¡ ´ëÇÑ ¼Ò°³¹× guide·Î
- In Vitro Drug-Release Testing Using the Dialysis Sac Method
- In Vitro Drug Release Using the Reverse Dialysis Sac Method
- In Vitro Drug Release Using Apparatus 2 ( º¸Ãæ¼ö ¹Ýµå½Ã replenishmentµî ÇÊ¿ä,...)
- In Vitro Drug Release Using Apparatus 4
- etc,..
3. ÷ºÎÀÚ·áÀÇ 4-6 page
: ½Ã·áÀÇ »óÅ¿¡ µû¸¥ ºÐ¼®¹æ¹ýÀåºñ ¼±Åà ¿¹
- Emulsions and Suspensions : the paddle method (Apparatus 2) or the flow-thru method (Apparatus 4)
- Nanoparticles/Nanocrystal : sampling-separation technique or by monitoring changes in the light-scattering device
- Liposomes : USP Apparatus 4, using a flow-through cell fitted with a dialysis adapter,
- Implants : The flow-through cell (USP Apparatus 4)
- Drug-Eluting Stents : USP Apparatus 4 and 7 with stent holders
- In Situ Forming Gels : USP Apparatus 2 and 4